Clinical Study
Nitazoxanide in Acute Rotavirus Diarrhea: A Randomized Control Trial from a Developing Country
Table 1
Baseline and demographic characteristics of the study population.
| | Nitazoxanide group | Control group | value |
| Age, months (IQR) | 26 (8.7) | 25 (8.3) | 0.38 | Males (%) | 16 (64) | 17 (68) | 0.76 | Weight (kg) (IQR) | 11.3 (2.2) | 11.1 (2.8) | 0.28 | Median duration (IQR) of diarrhea before treatment (hours) | 42 (13) | 45 (11) | 0.35 | Stool consistency at the time of enrolment (%) | | | | Liquid | 11 (44) | 10 (40) | 0.24 | Semiliquid | 05 (20) | 07 (28) | Loose | 09 (36) | 08 (32) | Number (%) of children vomiting | 13 (52) | 11 (44) | 0.57 | Median (IQR) duration of vomiting (hours) | 28 (13) | 30 (12) | 0.4 | Number (%) of children with fever | 09 (36) | 07 (28) | 0.55 | Median (IQR) duration of fever (hours) | 30 (16) | 33 (15) | 0.47 | Dehydration status (%) | | | | Mild | 08 (32) | 09 (36) | 0.65 | Moderate | 13 (52) | 11 (44) |
|
|
IQR: Interquartile range.
|